|
1
|
Lee BS, Cha BH, Park EC and Roh J: Risk
factors for perihilar cholangiocarcinoma: A hospital-based
case-control study. Liver Int. 35:1048–1053. 2015. View Article : Google Scholar
|
|
2
|
Tringler B, Zhuo S, Pilkington G, Torkko
KC, Singh M, Lucia MS, Heinz DE, Papkoff J and Shroyer KR: B7-h4 is
highly expressed in ductal and lobular breast cancer. Clin Cancer
Res. 11:1842–1848. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Mavros MN, Economopoulos KP, Alexiou VG
and Pawlik TM: Treatment and prognosis for patients with
intrahepatic cholangiocarcinoma: Systematic review and
meta-analysis. JAMA Surg. 149:565–574. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Jarnagin WR and Shoup M: Surgical
management of cholangiocarcinoma. Semin Liver Dis. 24:189–199.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Seliger B, Marincola FM, Ferrone S and
Abken H: The complex role of B7 molecules in tumor immunology.
Trends Mol Med. 14:550–559. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sica GL, Choi IH, Zhu G, Tamada K, Wang
SD, Tamura H, Chapoval AI, Flies DB, Bajorath J and Chen L: B7-H4,
a molecule of the B7 family, negatively regulates T cell immunity.
Immunity. 18:849–861. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Prasad DVR, Richards S, Mai XM and Dong C:
B7S1, a novel B7 family member that negatively regulates T cell
activation. Immunity. 18:863–873. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zheng X, Li XD, Wu CP, Lu BF and Jiang JT:
Expression of costimulatory molecule B7-H4 in human malignant
tumors. Onkologie. 35:700–705. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Basta P, Galazka K, Mach P, Jozwicki W,
Walentowicz M and Wicherek L: The immunohistochemical analysis of
RCAS1, HLA-G, and B7H4-positive macrophages in partial and complete
hydatidiform mole in both applied therapeutic surgery and surgery
followed by chemotherapy. Am J Reprod Immunol. 65:164–172. 2011.
View Article : Google Scholar
|
|
10
|
Tian F, Li D, Chen J, Liu W, Cai L, Li J,
Jiang P, Liu Z, Zhao X, Guo F, et al: Aberrant expression of GATA
binding protein 6 correlates with poor prognosis and promotes
metastasis in cholangiocarcinoma. Eur J Cancer. 49:1771–1780. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
He Q, Cai L, Shuai L, Li D, Wang C, Liu Y,
Li X, Li Z and Wang S: Ars2 is overexpressed in human
cholangiocarcinomas and its depletion increases PTEN and PDCD4 by
decreasing microRNA-21. Mol Carcinog. 52:286–296. 2013. View Article : Google Scholar
|
|
12
|
Li B, Wang Y, Chen J, Wu H and Chen W:
Identification of a new HLA-A*0201-restricted CD8+ T
cell epitope from hepatocellular carcinoma-associated antigen
HCA587. Clin Exp Immunol. 140:310–319. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yao Y, Chen L, Wei W, Deng X, Ma L and Hao
S: Tumor cell-derived exosome-targeted dendritic cells stimulate
stronger CD8+ CTL responses and antitumor immunities.
Biochem Biophys Res Commun. 436:60–65. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Mugler KC, Singh M, Tringler B, Torkko KC,
Liu W, Papkoff J and Shroyer KR: B7-h4 expression in a range of
breast pathology: Correlation with tumor T-cell infiltration. Appl
Immunohistochem Mol Morphol. 15:363–370. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Smith JB, Stashwick C and Powell DJ Jr:
B7-H4 as a potential target for immunotherapy for gynecologic
cancers: A closer look. Gynecol Oncol. 134:181–189. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang X, Wang T, Xu M, Xiao L, Luo Y, Huang
W, Zhang Y and Geng W: B7-H4 overexpression impairs the immune
response of T cells in human cervical carcinomas. Hum Immunol.
75:1203–1209. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Drescher KM and Lynch HT: Tumor
infiltrating lymphocytes (TILs): Lessons learned in 30 years of
study. Clin Appl Immunol Rev. 5:149–166. 2005. View Article : Google Scholar
|
|
18
|
Plentz RR and Malek NP: Clinical
presentation, risk factors and staging systems of
cholangiocarcinoma. Best Pract Res Clin Gastroenterol. 29:245–252.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Nathan H, Pawlik TM, Wolfgang CL, Choti
MA, Cameron JL and Schulick RD: Trends in survival after surgery
for cholangiocarcinoma: A 30-year population-based SEER database
analysis. J Gastrointest Surg. 11:1488–1497. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chen LJ, Sun J, Wu HY, Zhou SM, Tan Y, Tan
M, Shan BE, Lu BF and Zhang XG: B7-H4 expression associates with
cancer progression and predicts patient's survival in human
esophageal squamous cell carcinoma. Cancer Immunol Immunother.
60:1047–1055. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Krambeck AE, Thompson RH, Dong H, Lohse
CM, Park ES, Kuntz SM, Leibovich BC, Blute ML, Cheville JC and Kwon
ED: B7-H4 expression in renal cell carcinoma and tumor vasculature:
Associations with cancer progression and survival. Proc Natl Acad
Sci USA. 103:10391–10396. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhu J, Chu B-F, Yang Y-P, Zhang SL, Zhuang
M, Lu WJ and Liu YB: B7-H4 expression is associated with cancer
progression and predicts patient survival in human thyroid cancer.
Asian Pac J Cancer Prev. 14:3011–3015. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Liu W, Shibata K, Koya Y, Kajiyama H,
Senga T, Yamashita M and Kikkawa F: B7-H4 overexpression correlates
with a poor prognosis for cervical cancer patients. Mol Clin Oncol.
2:219–225. 2014.PubMed/NCBI
|
|
24
|
Sun Y, Wang Y, Zhao J, Gu M, Giscombe R,
Lefvert AK and Wang X: B7-H3 and B7-H4 expression in non-small-cell
lung cancer. Lung Cancer. 53:143–151. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Jiang J, Zhu Y, Wu C, Shen Y, Wei W, Chen
L, Zheng X, Sun J, Lu B and Zhang X: Tumor expression of B7-H4
predicts poor survival of patients suffering from gastric cancer.
Cancer Immunol Immunother. 59:1707–1714. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Tringler B, Liu W, Corral L, Torkko KC,
Enomoto T, Davidson S, Lucia MS, Heinz DE, Papkoff J and Shroyer
KR: B7-H4 overexpression in ovarian tumors. Gynecol Oncol.
100:44–52. 2006. View Article : Google Scholar
|
|
27
|
Dunn GP, Old LJ and Schreiber RD: The
immunobiology of cancer immunosurveillance and immunoediting.
Immunity. 21:137–148. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Chiou SH, Sheu BC, Chang WC, Huang SC and
Hong-Nerng H: Current concepts of tumor-infiltrating lymphocytes in
human malignancies. J Reprod Immunol. 67:35–50. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Chen C, Qu QX, Shen Y, Mu CY, Zhu YB,
Zhang XG and Huang JA: Induced expression of B7-H4 on the surface
of lung cancer cell by the tumor-associated macrophages: A
potential mechanism of immune escape. Cancer Lett. 317:99–105.
2012. View Article : Google Scholar
|
|
30
|
Wang X, Hao J, Metzger DL, Ao Z, Chen L,
Ou D, Verchere CB, Mui A and Warnock GL: B7-H4 treatment of T cells
inhibits ERK, JNK, p38, and AKT activation. PLoS One. 7:e282322012.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Salceda S, Tang T, Kmet M, Munteanu A,
Ghosh M, Macina R, Liu W, Pilkington G and Papkoff J: The
immunomodulatory protein B7-H4 is overexpressed in breast and
ovarian cancers and promotes epithelial cell transformation. Exp
Cell Res. 306:128–141. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kryczek I, Wei S, Zhu G, Myers L, Mottram
P, Cheng P, Chen L, Coukos G and Zou W: Relationship between B7-H4,
regulatory T cells, and patient outcome in human ovarian carcinoma.
Cancer Res. 67:8900–8905. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Liu SJ, Tsai JP, Shen CR, Sher YP, Hsieh
CL, Yeh YC, Chou AH, Chang SR, Hsiao KN, Yu FW, et al: Induction of
a distinct CD8 Tnc17 subset by transforming growth factor-beta and
interleukin-6. J Leukoc Biol. 82:354–360. 2007. View Article : Google Scholar : PubMed/NCBI
|
